Keyphrases
Implantable Defibrillator
100%
Cohort Description
100%
Design Description
100%
Gender Differences
66%
Patient-reported Outcomes
33%
Baseline Characteristics
33%
Clinical Outcomes
16%
Beta-blockers
16%
Depressive Symptoms
16%
Anxiety Symptoms
16%
Medical Records
16%
National Register
16%
Clinically Significant
16%
Psychosocial Outcomes
16%
Statins
16%
Angiotensin-converting Enzyme Inhibitor (ACEi)
16%
Shock
16%
Heart Disease
16%
Ventricular Arrhythmia
16%
Implantable Cardioverter-defibrillator Therapy
16%
Design Characteristics
16%
Multicenter Observational Study
16%
Clinical Profile
16%
Procedural Complications
16%
Effect Size Estimation
16%
Real-life Cohort
16%
Cohen
16%
Device Complications
16%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
100%
Symptom
100%
Psychotropic Agent
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Heart Disease
100%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Implant
100%
Heart Ventricle Tachycardia
100%
Medicine and Dentistry
Implantable Automatic Defibrillator
100%
Sex Difference
57%
Patient-Reported Outcome
28%
Medical Record
14%
Symptom
14%
Observational Study
14%
Heart Disease
14%
Effect Size
14%
Implant
14%
Statin
14%
Shock (Circulatory)
14%
ACE Inhibitor
14%
Ventricular Tachycardia
14%
Psychological Outcome
14%
Psychoactive Drug
14%
Nursing and Health Professions
Implantable Cardioverter Defibrillator
100%
Gender Difference
57%
Patient-Reported Outcome
28%
Medical Record
14%
Symptom
14%
Heart Disease
14%
Effect Size
14%
Dipeptidyl Carboxypeptidase Inhibitor
14%
Implant
14%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
14%
Heart Ventricle Tachycardia
14%
Psychotropic Agent
14%
Neuroscience
Psychoactive Drug
100%
ACE Inhibitor
100%
Statin
100%
Psychology
Gender Difference
100%
Study Design
100%